Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
Veterans Affairs Northwest Network (VISN 20) Mental Illness Research, Education and Clinical Center, Mental Health Service, VA Puget Sound Health Care System, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA Email: murray.raskind@va.gov.
Murray A
MA
Raskind
Veterans Affairs Northwest Network (VISN 20) Mental Illness Research, Education and Clinical Center, Mental Health Service, VA Puget Sound Health Care System, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA Email: murray.raskind@va.gov.
Lucy Y
LY
Wang
D059331:Adrenergic Neurons / Q000187:drug effects; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003704:Dementia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D014150:Antipsychotic Agents